Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PBLA
|
Arthur Fratamico
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,875 Added 35.17% |
-
|
Dec 01
2020 |
|
PBLA
|
Donald Robert Schemel
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,875 Added 3.02% |
-
|
Dec 01
2020 |
|
PBLA
|
Jeffrey S Mathiesen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,875 Added 32.86% |
-
|
Dec 01
2020 |
|
PBLA
|
Paul W. Schaffer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 2,875 Added 1.74% |
-
|
Dec 01
2020 |
|
PTPI
|
John D Shulman
Director |
BUY
Grant, award, or other acquisition
|
Indirect | 3,382,416 Added 50.0% |
-
|
Dec 01
2020 |
|
PTPI
|
Keith Lavan
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Indirect | 975 Added 50.0% |
-
|
Dec 01
2020 |
|
PTPI
|
Andrew Gesek
President, Timm Medical |
BUY
Grant, award, or other acquisition
|
Indirect | 97 Added 50.0% |
-
|
Dec 01
2020 |
|
RAVE
|
Clinton Dayne Fendley
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 34,883 Added 38.5% |
$30,348
$0.87 p/Share
|
Dec 01
2020 |
|
WYY
|
Richard L Todaro
Director |
SELL
Open market or private sale
|
Direct | 26,797 Reduced 80.69% |
$269,042
$10.04 p/Share
|
Dec 01
2020 |
|
ASPU
|
Frank J Cotroneo
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 13,233 Reduced 24.46% |
-
|
Dec 01
2020 |
|
ASPU
|
Frank J Cotroneo
Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 33,333 Added 38.12% |
-
|
Dec 01
2020 |
|
ASPU
|
Robert Alessi
Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,265 Reduced 31.23% |
-
|
Dec 01
2020 |
|
ASPU
|
Robert Alessi
Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 6,667 Added 38.94% |
-
|
Dec 01
2020 |
|
PRPO
|
Ahmed Zaki Sabet
Chief Operating Officer |
BUY
Open market or private purchase
|
Direct | 222 Added 4.48% |
$495
$2.23 p/Share
|
Dec 01
2020 |
|
PRPO
|
Ilan Danieli
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 1,111 Added 5.16% |
$2,478
$2.23 p/Share
|
Dec 01
2020 |
|
MRIN
|
L Gordon Crovitz |
SELL
Open market or private sale
|
Direct | 13,600 Reduced 80.09% |
$29,512
$2.17 p/Share
|
Dec 01
2020 |
|
CTHR
|
Ollin B Sykes
Director |
BUY
Open market or private purchase
|
Indirect | 336 Added 0.03% |
$390
$1.16 p/Share
|
Dec 01
2020 |
|
MCVT
|
Laurence S Zipkin |
BUY
Open market or private purchase
|
Direct | 9,025 Added 14.31% |
$7,220
$0.8 p/Share
|
Dec 01
2020 |
|
FREQ
|
David L. Lucchino |
SELL
Open market or private sale
|
Direct | 15,714 Reduced 4.63% |
$444,392
$28.28 p/Share
|
Dec 01
2020 |
|
TESS
|
Lakeview Investment Group & Trading CO LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 9,000 Added 0.95% |
$57,330
$6.37 p/Share
|
Dec 01
2020 |
|
APCX
|
Michael B Gross |
SELL
Bona fide gift
|
Indirect | 1,000,000 Reduced 1.62% |
-
|
Dec 01
2020 |
|
APCX
|
Gary B Wachs
Chief Financial Officer |
SELL
Bona fide gift
|
Direct | 750,000 Reduced 9.89% |
-
|
Dec 01
2020 |
|
LVO
|
Robert S Ellin
CEO & Chairman |
BUY
Open market or private purchase
|
Direct | 1,400 Added 0.09% |
$3,584
$2.56 p/Share
|
Dec 01
2020 |
|
PCF
|
Phillip Goldstein
Director |
SELL
Open market or private sale
|
Direct | 254 Reduced 0.37% |
$2,134
$8.4 p/Share
|
Dec 01
2020 |
|
PCTI
|
Kevin J Mc Gowan
Vice President and CFO |
SELL
Payment of exercise price or tax liability
|
Direct | 489 Reduced 0.34% |
$3,076
$6.29 p/Share
|
Dec 01
2020 |
|
WRAP
|
Patrick Kinsella |
BUY
Exercise of conversion of derivative security
|
Direct | 35,000 Added 43.71% |
$126,350
$3.61 p/Share
|
Dec 01
2020 |
|
ELMD
|
Andrea M. Walsh
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 50.0% |
-
|
Dec 01
2020 |
|
ELMD
|
George H. Winn
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 2.14% |
-
|
Dec 01
2020 |
|
ELMD
|
A Jones Lee
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 12.41% |
-
|
Dec 01
2020 |
|
ELMD
|
Gregory Fluet
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 33.33% |
-
|
Dec 01
2020 |
|
ELMD
|
Stan K. Erickson
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 11.19% |
-
|
Dec 01
2020 |
|
ELMD
|
Stephen H. Craney
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,000 Added 0.52% |
-
|
Dec 01
2020 |
|
KLR
|
Avi S Katz
Director |
SELL
Other acquisition or disposition
|
Indirect | 2,592,309 Reduced 90.58% |
-
|
Dec 01
2020 |
|
KLR
|
Avi S Katz
Director |
BUY
Other acquisition or disposition
|
Direct | 1,394,005 Added 45.44% |
-
|
Dec 01
2020 |
|
KLR
|
Neil Miotto
Director |
BUY
Other acquisition or disposition
|
Direct | 154,890 Added 32.55% |
-
|
Dec 01
2020 |
|
BDTX
|
David M. Epstein |
SELL
Open market or private sale
|
Direct | 12,000 Reduced 1.68% |
$396,600
$33.05 p/Share
|
Dec 01
2020 |
|
BDTX
|
David M. Epstein |
BUY
Exercise of conversion of derivative security
|
Direct | 3,000 Added 0.42% |
$19,260
$6.42 p/Share
|
Dec 01
2020 |
|
SOTK
|
Joseph Riemer
Director |
SELL
Open market or private sale
|
Direct | 3,050 Reduced 3.77% |
$12,383
$4.06 p/Share
|
Dec 01
2020 |
|
SRZN
|
Kevin Harold Livingston |
BUY
Open market or private purchase
|
Indirect | 24,000 Added 5.24% |
-
|
Dec 01
2020 |
|
SRZN
|
Benny Soffer |
BUY
Open market or private purchase
|
Indirect | 24,000 Added 5.24% |
-
|
Dec 01
2020 |
|
SRZN
|
Life Sciences Consonance |
BUY
Open market or private purchase
|
Direct | 24,000 Added 5.24% |
-
|
Dec 01
2020 |
|
SRZN
|
Mitchell J Md Blutt
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 24,000 Added 5.24% |
-
|
Dec 01
2020 |
|
OBCI
|
Gregor M Dornau
EVP Sales & Marketing |
SELL
Open market or private sale
|
Direct | 750 Reduced 0.16% |
$10,073
$13.43 p/Share
|
Dec 01
2020 |
|
MLVF
|
James W Barrett
Director |
BUY
Open market or private purchase
|
Direct | 166 Added 1.29% |
$2,646
$15.94 p/Share
|
Dec 01
2020 |
|
MLVF
|
Julia D Corelli
Director |
BUY
Open market or private purchase
|
Direct | 166 Added 2.35% |
$2,646
$15.94 p/Share
|
Dec 01
2020 |
|
MLVF
|
Norman Feinstein
Director |
BUY
Open market or private purchase
|
Indirect | 166 Added 1.26% |
$2,646
$15.94 p/Share
|
Dec 01
2020 |
|
MLVF
|
Andrew D. Fish
Director |
BUY
Open market or private purchase
|
Direct | 181 Added 4.23% |
$2,885
$15.94 p/Share
|
Dec 01
2020 |
|
MLVF
|
Howard Kent
Director |
BUY
Open market or private purchase
|
Direct | 239 Added 0.15% |
$3,810
$15.94 p/Share
|
Dec 01
2020 |
|
MLVF
|
Cynthia F Leitzell
Director |
BUY
Open market or private purchase
|
Direct | 197 Added 1.15% |
$3,140
$15.94 p/Share
|
Dec 01
2020 |
|
MLVF
|
Stephen P Scartozzi
Director |
BUY
Open market or private purchase
|
Direct | 196 Added 2.74% |
$3,124
$15.94 p/Share
|
Dec 01
2020 |